XENCOR
Xencor provides protein engineering technology platforms in the biotechnology industry. Its products include antibody therapeutics, such as XmAb2513 for the treatment of relapsed Hodgkin’s lymphoma and anaplastic large cell lymphoma; XmAb5574, a humanized monoclonal antibody that targets the antigen CD19 for the treatment of B cell malignancies; XmAb5592 for the treatment of myeloma; and XmAb5871 and XmAb7195, which are humanized monoclonal antibodies for the treatment of asthma and allergy. The company’s products also include XPro protein therapeutics, such as XPro1595, a dominant-negative inhibitor for the treatment of multiple animal models of autoimmune and neuroinflammatory diseases.
XENCOR
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
1997-01-01
Address:
Monrovia, California, United States
Country:
United States
Website Url:
http://www.xencor.com
Total Employee:
51+
Status:
Active
Contact:
626-305-5900
Email Addresses:
[email protected]
Total Funding:
133.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API WordPress Domain Not Resolving Wordpress Plugins Mobile Non Scaleable Content Sitelinks Search Box
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Applied Molecular Transport
Applied Molecular Transport developing novel, oral biological therapeutics to treat severe autoimmune, metabolic and inflammatory diseases.
Cerulean Pharma
Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Kinnate Biopharma
Kinnate Biopharma develops precision oncology therapeutics to treat patients with genomically-defined cancers.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Nimbus Therapeutics
Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical stage company.
Vetigenics
Vetigenics discovers and develops antibody-based immunotherapies to treat cancer and chronic diseases in companion animals
Zebra Biologics
Zebra Biologics develops bio superior agonist and antagonist antibody therapeutics for many diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Oxford Bioscience Partners
Oxford Bioscience Partners investment in Series E - Xencor
Novo Nordisk
Novo Nordisk investment in Series E - Xencor
Merlin Nexus
Merlin Nexus investment in Series E - Xencor
Zen Investments
Zen Investments investment in Series D - Xencor
Moore Capital
Moore Capital investment in Series C - Xencor
Sands Brothers Asset Management
Sands Brothers Asset Management investment in Series C - Xencor
Stafford Capital Partners
Stafford Capital Partners investment in Series C - Xencor
Stafford Capital Partners
Stafford Capital Partners investment in Series B - Xencor
Official Site Inspections
http://www.xencor.com Semrush global rank: 1.74 M Semrush visits lastest month: 13.58 K
Unable to get host informations!!!
